Evidence map›Paper›PMID 30771011›Full record

ArticleMikrochimica acta2019

A colorimetric ATP assay based on the use of a magnesium(II)-dependent DNAzyme.

Sha Zhu, Xiaoying Wang, Cheng Jing, Yongmei Yin, Nandi Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. DNAmoreDB, a database of DNAzymes.Nucleic acids research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sha ZhuDepartment of Oncology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, 214000, China.
Xiaoying WangDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Cheng JingThe Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiang nan University, Wuxi, 214122, China.
Yongmei YinDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. yinym_njmu@163.com.
Nandi ZhouThe Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiang nan University, Wuxi, 214122, China. zhounandi@jiangnan.edu.cn.
Nanjing Medical University · CNJiangnan University · CN

Funding

The High Level Innovation Team of Nanjing Medical University JX102GSP201727The National Key Research and Development Program: The key technology of palliative care and nursing for cancer patients ZDZX2017ZL-01the Science and Technology Development Foundation of Nanjing Medical University 2017NJMU175
6 · The paper itself

Abstract

A colorimetric assay for ATP is described that uses a strategy that combines the concept of split Mg(II)-dependent DNAzyme, split aptamer, and hybridization-induced aggregation of gold nanoparticles (AuNPs). Both ATP aptamer and Mg(II)-dependent DNAzyme are split into two fragments which are allocated to two well-designed DNA probes. The probes also possess mutually complementary stem sequences and spacer sequences. In the presence of ATP, the separated DNAzyme sequences in the two probes assemble via the synchronous recognition of ATP with two fragments of the aptamer. Then, the activated DNAzyme catalyzes multiple cycles of the cleavage of its substrate DNA sequence. The latter acts as a linker and induces the aggregation of two types of ssDNA-modified AuNP through the hybridization between the complementary sequences. Thus, the color of the AuNP solution remains red. However, in the absence of ATP, the detached aptamer cannot induce the assembly of DNAzyme to cleave the linker DNA. This results in the aggregation of AuNP and a concomitant color transition from red to purple. This ATP assay, performed at a wavelength of 530 nm, has a linear detection range that extends from 10 pM to 100 nM, with a detection limit of 5.3 pM. It was applied to the detection of ATP in human serum. Conceivably, the strategy has a wide scope in that it may be applied to the colorimetric detection of various other analytes through the split aptamer configuration. Graphical abstract Schematic presentation of colorimetric assay for adenosine triphosphate (ATP) based on the use of a split Mg(II)-dependent DNAzyme, a split aptamer, and by exploiting the hybridization-induced aggregation of gold nanoparticles that leads to a color change from red to purple.

Indexed as

Adenosine TriphosphateAptamers, NucleotideBase SequenceBiosensing TechniquesColorColorimetryDNA, CatalyticDNA ProbesDNA, Single-StrandedGoldHumansLimit of DetectionMagnesiumMetal NanoparticlesNucleic Acid HybridizationAdenosine TriphosphateAptamers, NucleotideDNA, CatalyticDNA ProbesDNA, Single-StrandedGoldMagnesiumAptasensorColorimetric detectionDNA probeGold nanoparticlesLabel-free biosensorLinker DNAMetal-ion dependent enzymeSerum analysisSplit aptamer

Identifiers

PMID30771011
OpenAlexW2914857929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.